<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02805036</url>
  </required_header>
  <id_info>
    <org_study_id>PI2015_843_0002</org_study_id>
    <nct_id>NCT02805036</nct_id>
  </id_info>
  <brief_title>Comparison of the Hemodynamic Safety of Two Common Alveolar Recruitment Manoeuvres With Regard to Cardiac Output in a Surgical Intensive Care Unit</brief_title>
  <acronym>RHERA1</acronym>
  <official_title>Comparison of the Hemodynamic Safety of Two Common Alveolar Recruitment Manoeuvres With Regard to Cardiac Output in a Surgical Intensive Care Unit: a Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Protective ventilation - combining a low tidal volume (between 6 and 8 ml/kg) and alveolar&#xD;
      recruitment (AR) manoeuvres repeated every 30 minutes - is currently the standard of care for&#xD;
      decreasing morbidity associated with mechanical ventilation.&#xD;
&#xD;
      In contrast, there is no consensus on the type of recruitment manoeuvre, which varies from&#xD;
      one centre to another and from one study to another.&#xD;
&#xD;
      The investigators intend to compare two currently used AR techniques with regard to their&#xD;
      ventilatory efficacy and hemodynamic safety:&#xD;
&#xD;
        -  An end-tidal plateau at 30 cmH20 for 30 seconds.&#xD;
&#xD;
        -  An end-tidal plateau at 10 cmH20 above the patient's plateau pressure for 30 seconds,&#xD;
           without exceeding 30 cmH20.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Variations in cardiac output induced by each type of AR manoeuvre</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Variations in PaO2 variations induced by each type of AR manoeuvre</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Positive-Pressure Respiration</condition>
  <arm_group>
    <arm_group_label>30 cmH20 for 30 seconds</arm_group_label>
    <description>plateau pressure is hold on at 30 cmH20 pour 30 seconds. The cardiac output and the lung aeration is assessed by ultrasound measures at 3 times: before, at the end of the recruitment and 30 minutes later.&#xD;
echocardiography - arterial oximetry</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 cmH20 above</arm_group_label>
    <description>plateau pressure is hold on at 10 cmH20 above. The cardiac output and the lung aeration is assessed by ultrasound measures at 3 times: before, at the end of the recruitment and 30 minutes later.&#xD;
echocardiography - arterial oximetry</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>echocardiography</intervention_name>
    <description>• Prospective, simultaneous recording of the cardiac output (measured non-invasively via transthoracic echocardiography) and a number of parameters commonly monitored in the surgical intensive care unit (CVP, SBP/DBP/MBP).</description>
    <arm_group_label>10 cmH20 above</arm_group_label>
    <arm_group_label>30 cmH20 for 30 seconds</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arterial oximetry</intervention_name>
    <description>measured by co-oximetry of a blood sample taken via the arterial catheter implemented for critical care</description>
    <arm_group_label>10 cmH20 above</arm_group_label>
    <arm_group_label>30 cmH20 for 30 seconds</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        sedated, intubated, mechanically ventilated adult patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All sedated, intubated, mechanically ventilated adult patients (over-18) admitted to&#xD;
             the surgical intensive care unit and equipped with a central venous catheter and an&#xD;
             arterial catheter.&#xD;
&#xD;
          -  Good echogenicity&#xD;
&#xD;
          -  Social security coverage&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Cardiac arrhythmia&#xD;
&#xD;
          -  Poor echogenicity&#xD;
&#xD;
          -  Legal guardianship or incarceration&#xD;
&#xD;
          -  Systolic blood pressure ≤90 mmHg&#xD;
&#xD;
          -  Respiratory distress&#xD;
&#xD;
          -  Patients admitted on an emergency basis (first 24 hours), i.e. not for elective&#xD;
             surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel LORNE, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <study_first_submitted>June 15, 2016</study_first_submitted>
  <study_first_submitted_qc>June 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2016</study_first_posted>
  <last_update_submitted>February 22, 2017</last_update_submitted>
  <last_update_submitted_qc>February 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>alveolar recruitment</keyword>
  <keyword>stroke volume/physiology</keyword>
  <keyword>cardiac output/physiology</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

